People with cystic fibrosis (CF) who develop related diabetes (CFRD) have accelerated pulmonary decline, increased infection with antibiotic-resistant Pseudomonas aeruginosa and increased pulmonary exacerbations. We have previously shown that glucose concentrations are elevated in airway surface liquid (ASL) of people with CF, particularly in those with CFRD. We therefore explored the hypotheses that glucose homeostasis is altered in CF airway epithelia and that elevation of glucose flux into ASL drives increased bacterial growth, with an effect over and above other cystic fibrosis transmembrane conductance regulator (CFTR)-related ASL abnormalities. The aim of this study was to compare the mechanisms governing airway glucose homeostasis in CF and non-CF primary human bronchial epithelial (HBE) monolayers, under normal conditions and in the presence of Ps. aeruginosa filtrate. HBE-bacterial co-cultures were performed in the presence of 5 mM or 15 mM basolateral glucose to investigate how changes in blood glucose, such as those seen in CFRD, affects luminal Ps. aeruginosa growth. Calu-3 cell monolayers were used to evaluate the potential importance of glucose on Ps. aeruginosa growth, in comparison to other hallmarks of the CF ASL, namely mucus hyperviscosity and impaired CFTR-dependent fluid secretions. We show that elevation of basolateral glucose promotes the apical growth of Ps. aeruginosa on CF airway epithelial monolayers more than non-CF monolayers. Ps. aeruginosa secretions elicited more glucose flux across CF airway epithelial monolayers compared to non-CF monolayers which we propose increases glucose availability in ASL for bacterial growth. In addition, elevating basolateral glucose increased Ps. aeruginosa growth over and above any CFTR-dependent effects and the presence or absence of mucus in Calu-3 airway epithelia-bacteria co-cultures. Together these studies highlight the importance of glucose as an additional factor in promoting Ps. aeruginosa growth and respiratory infection in CF disease.
Introduction
The airway epithelium is covered by a thin layer of surface liquid (ASL), which is vital for maintaining a healthy respiratory tract. It is now well established in cystic fibrosis (CF) that a lack of functional cystic fibrosis transmembrane conductance regulator (CFTR) impairs airway bicarbonate and fluid secretion producing an acidic, viscous ASL [1, 2, 3] that is readily colonised by bacteria such as Pseudomonas aeruginosa [4] . Much has been made of the defective anti-microbial properties of the CF ASL and of changes in host-pathogen responses across the CF airway epithelium. However, relatively little has been reported on disease-related changes in the nutritional content of ASL, such as elevated glucose concentrations, that could stimulate bacterial growth in CF airways.
In people with CF, coexisting diabetes mellitus (CF-related diabetes; CFRD) is associated with an increased risk of infection with multiple antibiotic-resistant Ps. aeruginosa. Patients with CFRD have more pulmonary exacerbations, which are less likely to respond to intravenous antibiotics, than those without diabetes [5] . We have previously shown that ASL glucose concentrations are elevated in patients with CF (,2 mM; compared to ,0.4 mM in healthy individuals) and are further elevated in CFRD to ,4 mM [6] . In intubated patients on intensive care, we found that elevated glucose concentrations in bronchial aspirates were associated with the presence and acquisition of respiratory pathogens [7] . In mice, glucose concentrations were elevated in lung secretions from diabetic compared to wild-type animals and bacterial load was greater in the airways of diabetic than wild-type mice [8, 9] . In human airway epithelial cells grown at air-liquid interface, elevation of basolateral glucose concentrations increased ASL glucose concentrations and directly promoted the growth of respiratory pathogens such as Ps. aeruginosa [8] .
ASL glucose concentration is the net effect of the paracellular diffusion of glucose from the blood/interstitial fluid across the airway epithelium into ASL and its removal from ASL by epithelial uptake through facilitative glucose transporters, GLUT2 and GLUT10 [9, 10, 11, 12] . We have previously shown that paracellular glucose diffusion is increased not only by elevating basolateral glucose concentrations (e.g. hyperglycaemia), but also by inflammation, which disrupts tight junction integrity. In human epithelial cell monolayers, we found that application of either apical pro-inflammatory cytokines [10] or apical bacterial pathogens [8] increased paracellular glucose flux, increasing glucose concentrations in ASL. Under pro-inflammatory conditions, airway epithelial glucose uptake through apical GLUTs is elevated, but this is insufficient to compensate for the increased paracellular glucose leak and does not prevent elevation of ASL glucose concentrations [10] . Control of paracellular glucose movement thus appears to be the main rate-limiting step for maintaining low ASL glucose concentrations. Since the CF airway epithelium is known to be more susceptible to inflammationinduced changes in tight junctions and paracellular permeability compared to non-CF epithelium [13] , we hypothesised that this may account for the elevation in ASL glucose concentrations observed in CF patients without diabetes, which is augmented further by hyperglycaemia in CFRD.
The aim of this study was to compare the mechanisms governing airway glucose homeostasis in polarized monolayers of CF and non-CF primary human bronchial epithelial (HBE) cells, under normal conditions and in the presence of Ps. aeruginosa filtrate. HBE-bacterial co-cultures were performed in the presence of 5 mM or 15 mM basolateral glucose to investigate how changes in glucose concentration, such as those seen in CFRD, affect apical Ps. aeruginosa growth. In addition, Calu-3 human airway epithelial cell monolayers were used to evaluate the potential importance of glucose on Ps. aeruginosa growth, in comparison to other hallmarks of the CF ASL, namely mucus hyperviscosity and impaired cystic fibrosis transmembrane conductance regulator (CFTR)-dependent fluid secretions.
Methods

Primary Human Bronchial Epithelial Cell Culture
Primary human bronchial epithelial (HBE) cells (non-CF and CF) were obtained from endobronchial brushings or extracted from explanted lungs and cultured as previously described [14, 15, 16] . HBE cells were obtained in accordance with approval from the relevant ethics committees and informed written consent from all study patients: Newcastle and North Tyneside Local Regional Ethics Committee (reference number 2001/179 and 07/ Q0906/47); The University of North Carolina at Chapel Hill Biomedical Institutional Review Board (protocol #03-1396). Cells were transferred onto clear Costar TranswellH inserts (0.45-mm pore size) and grown at air-liquid-interface (ALI) to form confluent monolayers. Cells were studied 3-5 weeks post-seeding.
Calu-3 Cell Culture
The human adenocarcinoma-derived cell line, Calu-3 (from ATCC), was grown in Eagle's minimal essential medium (EMEM) plus 10% FCS, 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin, and 1% non-essential amino acids (Sigma) and incubated in humidified air containing 5% CO 2 at 37uC.
Calu-3 cells were seeded onto clear Costar TranswellH inserts (0.45-mm pore size) at 250,000 cells/cm 2 to form confluent polarised monolayers, as previously described [17] . Experiments were carried out 10-14 days post-seeding. For studies examining the effect of a viscous mucus layer on bacterial growth in co-culture, Calu-3 monolayers were grown at ALI 5 days post-seeding on transwell supports. Under these conditions a thick mucus layer builds up on the apical surface which can be removed by washing the surface with PBS. 72 hours before the experiment, transwells were washed to remove the mucus layer and placed in Krebs salt solution consisting of 115 mM NaCl, 5 mM KCl, 25 mM NaHCO 3 , 1 mM MgCl 2 , 1 mM CaCl 2 and 5 mM D-glucose (equilibrated with 5% CO 2 to pH 7.4) to remove antibiotics and components of the media that could influence bacterial growth. The cells were incubated to allow the mucus layer to re-form. The transwells were then divided into two parallel sets. One set of transwells were re-washed to remove this layer just prior to experimentation, while another set were lightly washed to preserve the mucus layer.
Ps. aeruginosa Culture
Ps. aeruginosa strain PA01 was used for the experiments. A single colony of PA01 was incubated overnight at 37uC in EMEM (containing 5 mM glucose) to form a culture of approximately 5610 9 colony forming units (CFU)/ml. Ps. aeruginosa filtrate was prepared by boiling (10 minutes), centrifuging (5,5006G for 30 minutes) and then filtering (0.45 mm pore filter) the overnight bacterial culture, as previously described [18] . The filtrate was diluted 1:10 in glucose-free media prior to addition to airway epithelial cell cultures. It has previously been shown that 10% Ps. aeruginosa filtrate is not highly cytotoxic to HBE cells over a similar time course [19] . 14 C]-L-glucose plus 10 mM of non-radiolabelled equivalent glucose to the basolateral side of the transwells and 0.1 ml of glucose-free Krebs salt solution to the apical side. Apical and basolateral samples were taken after 1 h and the concentration of radiolabelled glucose was analysed using a scintillation counter.
[14C]-D-glucose uptake experiments on HBE monolayers were performed as previously described [10] .
In vitro co-culture model
Bacterial cultures were diluted in glucose-free Krebs salt solution (composition described above). 50 ml or 100 ml of 1610 7 CFU/ml PA01 was applied to the apical surface of HBE or Calu-3 cell monolayers, respectively. The basolateral side of the airway epithelial-bacterial co-cultures were washed and placed in Krebs salt solution 24 hours prior to co-culture experiments to remove antibiotics and components of the media that could influence bacterial growth. Normal blood glucose or hyperglycaemia was modelled by applying basolateral glucose concentrations of 5 and 15 mM, respectively. Co-cultures were placed in a CO 2 incubator at 37uC for 7 hours, after which each was homogenised and CFU calculated by plating out serial dilutions.
ASL glucose
To evaluate the effects of Ps. aeruginosa and/or basolateral glucose on the glucose concentration of the ASL overlying Calu-3 monolayers, the apical surface was washed and then 100 ml of glucose-free Krebs salt solution was placed onto the surface of monolayers with or without Ps. aeruginosa filtrate. The basolateral side was supplied with Krebs salt solution containing either 5 or 15 mM D-glucose. Cultures were left for 24 hours to equilibrate. Apical fluid was subsequently removed from the cell surface and glucose concentrations were measured using a glucose oxidase analyser (Analox Instruments, UK).
Transepithelial Liquid Secretion
The rate and pH of liquid secreted from Calu-3 monolayers was measured as previously described [17] , after 7 hours of co-culture with PA01.
Chemicals and reagents
All chemicals and reagents were obtained from Sigma, Poole, UK unless otherwise stated.
Statistical analysis
Values are reported as mean 6 S.E.M. Statistical analysis was performed using analysis of variance (ANOVA) and post hoc Bonferroni multiple comparison or Student's t test. P values ,0.05 were considered significant.
Results
CF airway epithelial monolayers exhibit similar rates of glucose uptake to non-CF monolayers
Comparison of 14 C-D-glucose uptake rates by non-CF and CF human bronchial epithelial (HBE) monolayers showed no significant difference in either apical or basolateral uptake ( Figure 1 ). Apical glucose uptake was 1.160.1 nmol/cm 2 /min and 1.060.1 nmol/cm 2 /min across non-CF and CF HBE monolayers, respectively (p.0.05, n = 3; Figure 1A ). Basolateral glucose was significantly higher than apical uptake in both cell types: 3.660.2 nmol/cm 2 /min and 2.960.3 nmol/cm 2 /min across non-CF and CF HBE monolayers, respectively (n = 3; Figure 1B ).
Ps. aeruginosa filtrate increases apical glucose uptake across human airway epithelial monolayers
The addition of Ps. aeruginosa filtrate to the apical surface (for 24 hours) led to an increase in apical, but not basolateral, Dglucose uptake by non-CF (58612% increase; p,0.05, n = 3; Figure 1A ) and CF (78614%; p,0.05, n = 3) HBE monolayers. No significant difference in Ps. aeruginosa-induced glucose uptake was observed between non-CF and CF HBE monolayers (p.0.05, n = 3).
Ps. aeruginosa filtrate reduces transepithelial resistance and enhances paracellular glucose flux across CF epithelium to a greater extent than non-CF epithelium
Comparison of the transepithelial resistance (R T ; Figure 2A ) and the paracellular basolateral-to-apical flux of L-glucose ( Figure 2B ) across non-CF and CF HBE monolayers showed no significant difference between the cell types under control conditions (p.0.05, n = 3). However, addition of the bacterial filtrate to the apical surface of HBE monolayers (for 24 hours) produced a significant reduction in R T and a corresponding increase in the paracellular flux of glucose. Ps. aeruginosa filtrate induced a significantly larger decrease in R T across CF HBE monolayers (778641 V.cm 2 to 381656 V.cm 2 ; p,0.05, n = 6; Figure 2A ) compared to non-CF HBE monolayers (737655 V.cm 2 to 544642 V.cm 2 ; p,0.001, n = 6). Similarly, the Ps.
aeruginosa-induced increase in paracellular L-glucose flux was much greater across CF HBE monolayers (164619%; p,0.01, n = 4; Figure 2C ) compared to non-CF HBE monolayers (65610%, p,0.05, n = 4).
Elevating basolateral D-glucose concentration increases the growth of apical Ps. aeruginosa across airway epithelial monolayers
Ps. aeruginosa was added to the apical surface of non-CF HBE monolayers for 7 hours in the presence of 5 mM or 15 mM basolateral D-glucose. Increasing the basolateral concentration of D-glucose from 5 to 15 mM resulted in a 69613% increase in apical Ps. aeruginosa growth (p,0.05, n = 4; Figure 3A ). Increasing the L-glucose, rather than D-glucose, concentration in the basolateral solution did not enhance apical bacterial growth.
Basolateral glucose-induced growth of apical Ps. aeruginosa is greater across CF airway epithelial monolayers Interestingly, although elevation of basolateral glucose from 5 to 15 mM enhanced apical bacterial growth across both non-CF and CF HBE monolayers, the glucose-induced increase in Ps. aeruginosa Apical Ps. aeruginosa addition increases glucose flux across Calu-3 airway epithelial monolayers, resulting in elevated ASL glucose and D-glucose dependent bacterial growth
The addition of Ps. aeruginosa to the apical surface of Calu-3 monolayers for 7 hours increased basolateral-to-apical L-glucose flux across the monolayers in a dose-dependent manner (p,0.001, n = 3; Figure 4A ). To investigate whether increased flux resulted in elevated glucose in the ASL, Ps. aeruginosa filtrate was used to eliminate the possibility of bacterial glucose uptake affecting ASL concentration. Ps. aeruginosa filtrate increased the concentration of glucose present in the ASL from 0.660.1 mM to 1.160.1 mM (p,0.05, n = 3; Figure 4B ). Increasing the basolateral concentration of D-glucose from 5 to 15 mM further increased ASL glucose concentrations from 1.160.1 mM to 5.860.8 mM (p,0.001, n = 3). When the growth of Ps. aeruginosa applied to the apical surface of Calu-3 monolayers was measured after 7 hours, increasing the basolateral concentration of D-glucose, but not Lglucose, resulted in an increase in growth from 4.761.0 CFU (x10 7 )/ml to 9.160.7 CFU (610 7 )/ml (an increase of 94619%; p,0.01, n = 6; Figure 4C ), consistent with our observations in non-CF and CF HBE cells.
Increasing basolateral glucose enhances apical Ps. aeruginosa growth on Calu-3 monolayers over and above the effects of CFTR-dependent secretions and mucus hyperviscosity
In order to gauge the potential importance of glucose-induced changes in bacterial growth in comparison to other hallmark abnormalities of the CF ASL, co-cultures were performed on Calu-3 airway epithelial cells. Calu-3 cultures are heterogeneous, consisting of both serous (fluid-secreting) and mucous (mucinsecreting) cell types, which produce CFTR-dependent secretions. Addition of the cAMP-agonist forskolin, which stimulates CFTR-dependent fluid secretion from these cells [17] , significantly reduced Ps. aeruginosa growth by 6368% (in the presence of 5 mM basolateral glucose; p,0.001, n = 6; Figure 5A ). However, Ps. aeruginosa growth remained higher in 15 mM glucose compared to 5 mM during forskolin stimulation (4.660.5 CFU (610 7 )/ml in 15 mM glucose, compared to 1.760.2 CFU (610 7 )/ml in 5 mM glucose; p,0.05, n = 6; Figure 5A ). Forskolin-stimulated cocultures increased the apical fluid volume by 761 ml after 7 hours (p,0.05, n = 6; Figure 5B ) and the pH of the apical fluid increased from 7.4360.02 to 7.5160.03 pH units (p,0.05, n = 4; Figure 5C ). The forskolin-mediated inhibition of Ps. aeruginosa growth could be partially overcome by the CFTR pore blocker GlyH-101 (p,0.05, n = 6; Figure 5A ). However, the CFTR blocker had no effect on the 15 mM glucose-induced increase in Ps. aeruginosa growth. Although inhibiting CFTR abolished the forskolin-stimulated increase in apical fluid volume (p,0.05, n = 6;
Figure 5B), it had no effect on the forskolin-induced alkalinisation (p.0.05, n = 4; Figure 5C ). These data indicate that CFTR ion conductance is important for ASL antimicrobial activity but that elevation of basolateral glucose from 5 to 15 mM promotes Ps. aeruginosa growth irrespective of CFTR activity.
Calu-3 monolayers grown at ALI generate a thick layer of mucus on the apical surface over time. The presence of this mucus layer increased Ps. aeruginosa CFU by 5767%, compared to monolayers in which the mucus layer had been removed (in the presence of 5 mM basolateral glucose; p,0.05, n = 4; Figure 6 ). Importantly, elevating basolateral glucose increased Ps. aeruginosa CFU in the presence or absence of mucus (p,0.05, n = 4; Figure 6 ).
Basolateral glucose alters airway epithelial monolayer transepithelial resistance
Interestingly, we found that elevating the basolateral glucose concentration reduced transepithelial resistance (R T ). Increasing basolateral glucose from 5 to 15 mM decreased Calu-3 monolayer R T from 11606115 V.cm 2 to 816683 V.cm 2 (p,0.05, n = 6; Figure 7 ). A similar glucose-induced decrease in Calu-3 R T was also observed after 7 hours of co-culture with 1610 6 CFU/cm 2 Ps. aeruginosa, although this effect is likely to be, at least in part, due to the elevated growth of the bacteria in the presence of increased basolateral glucose. At higher bacteria inoculations, no significant difference in Calu-3 R T was observed between glucose concentrations (p.0.05, n = 6).
Discussion
We have previously shown that ASL glucose concentrations are elevated in people with chronic lung inflammation, including those with CF [6, 20] . ASL glucose concentrations are also increased by hyperglycaemia [6] . Diabetes mellitus is a common comorbidity with CF and the combination of lung inflammation and hyperglycaemia produces a further increase in ASL glucose concentrations [6] . Figure 5 . Increasing basolateral glucose enhances apical Ps. aeruginosa growth across Calu-3 monolayers over and above the effects of CFTR-dependent secretions. A: Ps. aeruginosa growth over 7 hours across the apical surface of untreated or forskolinstimulated Calu-3 monolayers (6CFTR pore blocker GlyH-101), in the presence of 5 mM or 15 mM basolateral D-glucose. n = 6 in each group, obtained from 3 independent experiments. * p,0.05, *** p,0.001. B: Changes in the apical fluid volume ( ml) of Ps. aeruginosa-Calu-3 cocultures over 7 hours (starting volume = 100 ml). n = 6 in each group, obtained from 3 independent experiments. * p,0.05. C: Changes in the pH of apical fluid from Ps. aeruginosa-Calu-3 co-cultures over 7 hours. n = 6 in each group, obtained from 3 independent experiments. * p,0.05. doi:10.1371/journal.pone.0076283.g005 Figure 6 . Increasing basolateral glucose enhances apical Ps. aeruginosa growth across Calu-3 monolayers over and above the effects of mucus hyperviscosity. Ps. aeruginosa growth over 7 hours across the apical surface of Calu-3 monolayers with or without a viscous mucus layer, in the presence of 5 mM or 15 mM basolateral Dglucose. n = 4 in each group, obtained from 4 independent experiments. * p,0.05. doi:10.1371/journal.pone.0076283.g006
Elevated ASL glucose concentrations are associated with an increased risk of respiratory infection and diabetes is a predisposing factor for acquisition of multiple antibiotic resistant Ps. aeruginosa and increased pulmonary exacerbations in people with CF [5] . The aims of this study were to use human airway epithelial cell culture models to explore mechanisms underlying the relationship between changes in ASL glucose and increased susceptibility to infection in CF.
We found that exposure to Ps. aeruginosa filtrate or live Ps. aeruginosa, decreased transepithelial resistance (R T ) and increased paracellular glucose flux across human airway epithelial monolayers, consistent with our previous observations [8] . Ps. aeruginosa, in addition to cell-associated virulence factors such as LPS, pili and flagella, which can activate inflammatory responses via toll-like receptors (TLRs) [21] , secrete an arsenal of factors that can damage the airway epithelium and alter cellular processes. Secreted proteases such as alkaline protease (AprA), endotoxins such as pyocyanin, ExoS, -T, -Y and rhamnolipids have all been shown to modify tight junction structure leading to decreased barrier function and contribute to the pathophysiology of CF disease [22, 23, 24] . Since the Ps. aeruginosa filtrate was boiled it is likely that its effects on the epithelium were due to heat-resistant secretions by the bacterium. Importantly, Ps. aeruginosa filtrate induced a greater increase in paracellular flux and reduction in R T across CF than non-CF epithelia monolayers. This is consistent with previous observations that tight junctions are abnormal in CF airway epithelium and that CF epithelia display increased paracellular permeability to both solutes and ions in the presence of pro-inflammatory stimuli compared to normal airway cells [13, 25] .
R T was also reduced by raising basolateral glucose. It is not clear what mechanisms are involved in the response to hyperglycaemia, but it could involve changes in AMPK activity [26] , proinflammatory cytokine release or glucose transporter activity [27] ; all of which can modify tight junctions. In Calu-3 cells we measured ASL glucose concentration and found this to be increased by Ps. aeruginosa filtrate and further by elevation of basolateral glucose concentrations. Thus, our experimental conditions mimic the state of the airways in patients with CFRD, where inflammation, Ps. aeruginosa infection and hyperglycaemia could all increase paracellular permeability and drive movement of glucose into the ASL.
Glucose is removed from ASL by apical glucose transport. We have previously shown in human H441 airway cells that proinflammatory stimuli increase GLUT2 and GLUT10 abundance and apical glucose uptake [10] . However, this was insufficient to prevent elevation of ASL glucose, as paracellular glucose flux exceeded uptake. Similarly, in the current study, apical glucose uptake was increased in both non-CF and CF epithelial cell monolayers by exposure to Ps. aeruginosa filtrate. Interestingly, there was no difference in the stimulated apical glucose uptake between the two cell types, despite the much greater increase in paracellular glucose flux across the CF monolayers. Thus, we propose that under pro-inflammatory conditions, glucose uptake is not sufficient to compensate the increased flux of glucose into ASL, particularly in CF epithelial cells.
Elevation of basolateral D-glucose evoked an increase in apical Ps. aeruginosa growth in all airway epithelial co-culture models investigated in this study. Ps. aeruginosa utilises glucose as a growth substrate [20] and so increased growth appears to be a direct effect of increased availability of this nutrient. In support of this hypothesis, increased basolateral L-glucose, which diffuses across the tight junctions in the same way as D-glucose but is not commonly metabolised by bacteria [28] , did not stimulate the growth of apical Ps. aeruginosa. Furthermore, the growth of Ps. aeruginosa was greater in the lungs of hyperglycemic than of normoglycemic mice, but there was no enhanced growth of a mutant strain of Ps. aeruginosa (PA01) with a defect in a gene (edd) required for catabolism of glucose [9] .
Elevation of basolateral glucose from 5 to 15 mM had a greater effect on apical growth of Ps. aeruginosa on CF compared to non-CF monolayers. We speculate that the combination of increased paracellular permeability in CF monolayers with an elevated basolateral-to-apical glucose gradient further increased the availability of glucose to the bacteria, enhancing growth. In laboratory culture we have previously shown a dose-dependent effect of glucose, at concentrations found in airway surface liquid, on bacterial growth [20] .
Currently, there is much research into how the lack of CFTR function in CF might affect ASL volume, composition and pH to alter bacterial growth [4, 29] . Impaired fluid secretion and hyperabsorption in CF result in thick viscous mucus, which is also thought to promote bacterial growth. Consistent with this notion, we found that the presence of a thick layer of mucus in Calu-3 cells increased the growth of Ps. aeruginosa. In Calu-3 cells, we found that forskolin (a cAMP agonist and activator of CFTR) increased fluid secretion, elevated pH and reduced bacterial growth. The CFTR pore blocker (GlyH-101) inhibited forskolininduced fluid secretion, but did not reduce the forskolin-induced ASL alkalinisation. Under these circumstances bacterial growth was partially restored, but not to levels observed under control conditions. This indicates that forskolin stimulates both CFTRdependent and -independent effects on bacterial growth. The forskolin-induced CFTR-dependent inhibition of Ps. aeruginosa growth was associated with increased ASL fluid volume. Interestingly, in support of this finding, reduced CFTR expression and depletion of ASL fluid volume has been proposed to produce a more suitable environment for Ps. aeruginosa colonisation in the lung [30, 31] . The forskolin-induced elevation of ASL pH was CFTR-independent. These findings are consistent with previous studies of Calu-3 fluid secretions, which identified the anion exchanger pendrin (also activated by elevation of cAMP), and not CFTR, as a key mediator of bicarbonate secretion from these cells [17] . Our data show that elevation of ASL pH was associated with decreased bacterial growth and elevated ASL pH is known to increase the activity of pH-sensitive antimicrobials [4] .
Crucially, even in the context of these well-recognised CFrelated abnormalities, elevation of basolateral glucose had a marked additional stimulatory effect on bacterial growth. In people with CF, the development of diabetes is associated with accelerated pulmonary decline, increased risk of infection with multiple antibiotic-resistant Ps. aeruginosa [5] and increased pulmonary exacerbations [32] . These data provide evidence that increased glucose leak into ASL as a consequence of rising blood glucose and worsening lung inflammation could provide an additional stimulus respiratory infection and augment the effects of other CF-related abnormalities.
Conclusions
We have shown that elevation of basolateral glucose promotes the apical growth of Ps. aeruginosa on CF airway epithelial monolayers more than non-CF monolayers. Ps. aeruginosa secretions induced an elevated glucose leak across CF airway epithelial monolayers compared to non-CF monolayers which we propose increases ASL glucose availability for bacterial growth. In addition, elevating basolateral glucose increased Ps. aeruginosa growth over and above the effects of CFTR-dependent fluid secretions and mucus in Calu-3 epithelial-bacterial co-cultures. Together these studies highlight the potential importance of glucose in promoting Ps. aeruginosa growth and respiratory infection in CF and CF-related diabetes and identify potential new targets for the prevention and treatment of CF pulmonary infection.
